The Motley Fool

Why these ASX shares just stormed to 52-week highs

With the market returning to form on Monday after a few wobbles last week, a good number of shares raced notably higher yesterday. Some even managed to climb to 52-week highs or better.

Three which achieved this milestone are listed below. Here’s why they are flying high right now:

The Baby Bunting Group Ltd (ASX: BBN) share price climbed to a record high of $3.76 on Monday. The baby products retailer’s shares have been on the rise since the release of its full year results in August. In FY 2019 Baby Bunting returned to form and posted a 19% increase in total sales to $362.3 million and a massive 58.2% lift in net profit to $15.1 million. This was driven largely by a reduction in competition and discounting activities. Looking ahead, management expects similarly strong growth in FY 2020 and has provided net profit after tax growth guidance of up to 46%. 

The Clover Corporation Limited (ASX: CLV) share price has continued its impressive run and hit a record high of $3.29 on Monday. The infant formula ingredients supplier’s shares have been on fire since the release of its full year results in September. In FY 2019 Clover reported a 21.8% increase in revenue to $76.7 million and a 33.1% lift in net profit after tax to $10.1 million. This was driven largely by increasing demand for infant formula.

The ResApp Health Ltd (ASX: RAP) share price hit a two-year high of 38 cents on Monday. The digital health company’s shares have been surging higher over the last couple of weeks thanks to two key developments. The first was the release of positive top-line results from its prospective, blinded at-home obstructive sleep apnoea study. Its smartphone app was able to accurately identify obstructive sleep apnoea when compared to a simultaneous at-home comprehensive sleep study. The second positive development was news that ResAppDx-EU has received Australian Therapeutics Goods Administration approval as a Class IIa medical device. This makes it the world’s first smartphone-based diagnostic test for acute paediatric respiratory disease.

Missed these gains? Then don't miss out on these hot stocks that have been tipped to race higher.

Our Top 3 Blue Chip Shares for 2020 – NOW AVAILABLE!

You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.

So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!

Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...

While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...

Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.

You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!

SimplyCLICK HERE FOR YOUR FREE REPORT!

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Clover Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

NEW. Five Cheap and Good Stocks to Buy in 2019…

Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield…

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

CLICK HERE FOR YOUR FREE REPORT!